全文获取类型
收费全文 | 6784篇 |
免费 | 916篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 145篇 |
妇产科学 | 187篇 |
基础医学 | 886篇 |
口腔科学 | 145篇 |
临床医学 | 591篇 |
内科学 | 1545篇 |
皮肤病学 | 350篇 |
神经病学 | 506篇 |
特种医学 | 274篇 |
外科学 | 1003篇 |
综合类 | 231篇 |
一般理论 | 2篇 |
预防医学 | 430篇 |
眼科学 | 276篇 |
药学 | 383篇 |
1篇 | |
中国医学 | 66篇 |
肿瘤学 | 666篇 |
出版年
2023年 | 54篇 |
2022年 | 78篇 |
2021年 | 232篇 |
2020年 | 178篇 |
2019年 | 271篇 |
2018年 | 280篇 |
2017年 | 271篇 |
2016年 | 285篇 |
2015年 | 364篇 |
2014年 | 401篇 |
2013年 | 428篇 |
2012年 | 510篇 |
2011年 | 512篇 |
2010年 | 337篇 |
2009年 | 331篇 |
2008年 | 372篇 |
2007年 | 367篇 |
2006年 | 347篇 |
2005年 | 346篇 |
2004年 | 291篇 |
2003年 | 234篇 |
2002年 | 244篇 |
2001年 | 128篇 |
2000年 | 115篇 |
1999年 | 91篇 |
1998年 | 50篇 |
1997年 | 37篇 |
1996年 | 24篇 |
1995年 | 29篇 |
1994年 | 31篇 |
1993年 | 35篇 |
1992年 | 46篇 |
1991年 | 41篇 |
1990年 | 39篇 |
1989年 | 26篇 |
1988年 | 25篇 |
1987年 | 28篇 |
1986年 | 27篇 |
1985年 | 29篇 |
1984年 | 24篇 |
1983年 | 18篇 |
1981年 | 11篇 |
1979年 | 15篇 |
1978年 | 14篇 |
1977年 | 11篇 |
1975年 | 9篇 |
1974年 | 19篇 |
1972年 | 10篇 |
1971年 | 24篇 |
1970年 | 9篇 |
排序方式: 共有7768条查询结果,搜索用时 15 毫秒
1.
2.
Kow Chia Siang Ramachandram Dinesh Sangarran Hasan Syed Shahzad 《Journal of thrombosis and thrombolysis》2022,54(2):217-218
Journal of Thrombosis and Thrombolysis - 相似文献
3.
4.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献5.
Wai Man Mandy Chan Yik Weng Yew Thiam Seng Colin Theng Choon Fong Liew Hazel H Oon 《Singapore medical journal》2020,61(4):194
INTRODUCTIONPsoriasis is a chronic inflammatory condition that affects the skin and joints, and is associated with cardiovascular risk factors, including metabolic syndrome (MetS). We aimed to assess the prevalence of MetS in patients with psoriasis and determine whether there was a correlation between psoriasis severity and MetS in a Singapore population.METHODSThis was a cross-sectional study of patients with psoriasis, aged 18–69 years, who attended a tertiary dermatology referral centre in Singapore from October 2007 to February 2009. Fasting glucose, lipids, blood pressure, Psoriasis Area and Severity Index, and body mass index were measured. MetS was diagnosed in the presence of three or more criteria of the modified National Cholesterol Education Program Adult Treatment Panel III.RESULTSAmong 338 patients with psoriasis, there were 238 (70.4%) men and 100 (29.6%) women, who were Chinese (n = 228; 67.5%), Malay (n = 52; 15.4%) and Indian (n = 58; 17.2%). The prevalence of MetS was 45.1%. MetS was 44% more prevalent in patients older than 50 years (p = 0.02). Malay patients with psoriasis were significantly more likely to have hypertriglyceridaemia, elevated fasting plasma glucose and abdominal obesity. There was no significant correlation between psoriasis severity and risk of MetS.CONCLUSIONThe prevalence of MetS in patients with psoriasis in Singapore was 45.1%, or nearly threefold higher than the Singapore general population. Patients with psoriasis should be screened yearly for MetS and any modifiable cardiovascular risk factors should be actively controlled. 相似文献
6.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献7.
8.
9.
Three‐Dimensional Echocardiographic Evaluation of Mitral Apparatus during Preload Manipulation in Patients with Hypertrophic Cardiomyopathy
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Hyemoon Chung M.D. Ji Hyun Yoon M.D. Young Won Yoon M.D. Ph.D. Ji Young Chung B.N. Jung‐Joon Cha M.D. Jong‐Youn Kim M.D. Ph.D. Pil‐Ki Min M.D. Ph.D. Byoung‐Kwon Lee M.D. Ph.D. Bum‐Kee Hong M.D. Ph.D. Se‐Joong Rim M.D. Ph.D. Hyuck Moon Kwon M.D. Eui‐Young Choi M.D. Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(8):1261-1269
10.